FIRAPY Featured at the 24th JSVMR Annual Meeting with a Special Symposium and Two Research Presentations

November 2, 2025

On November 2, 2025, FIRAPY was honored to participate in the 24th Annual Meeting of the Japan Society of Vascular Medicine and Rheology (JSVMR), held at Saitama Medical Center of Dokkyo Medical University. The JSVMR is a prominent academic society composed mainly of professionals in cardiovascular and vascular medicine, focusing on advancements in hemodynamics, vascular biology, and innovative, non-invasive therapeutic approaches.

This year marked FIRAPY’s first official presence at JSVMR, with both a product exhibition booth and a lunch symposium that sparked strong engagement from the academic community.

A highlight of the event was the FIRAPY-sponsored lunch symposium, where Professor Yukihito Higashi of Hiroshima University—an esteemed researcher and New England Journal of Medicine contributor—was invited to deliver a keynote presentation. Professor Higashi gave a comprehensive overview of FIRAPY’s more than decade-long clinical and research history in Japan, and outlined important directions for future studies in vascular applications of far-infrared therapy.

In addition, two FIRAPY-related studies were presented during the conference:

  1. "The Effect of Combined Neuromuscular Electrical Stimulation and Far-Infrared Therapy on Peripheral Circulation in Healthy Subjects"
    Presented by Dr. Shota Sugai, this pilot study explored the synergistic effects of NMES and FIRAPY on improving peripheral circulation in healthy individuals. With Dr. Yasu Takanori (this year’s JSVMR Congress Chair) listed as a senior co-author, the study opens new possibilities in non-invasive approaches for vascular health.
  2. "Far-Infrared Radiation Promotes the Expression of Angiogenesis-Related Genes"
    Presented by
    Dr. Makoto Saito, this research provided molecular-level insights into FIRAPY’s role in upregulating angiogenesis-related gene expression, supporting its use in vascular regeneration and wound healing.

Thanks to Professor Higashi’s powerful lecture and the contributions of Dr. Sugai and Dr. Saito, FIRAPY’s booth received considerable attention throughout the event. Professor Higashi and Dr. Saito gathered at the booth to exchange insights on clinical usage, research findings, and potential applications of FIRAPY. Their conversations also laid the foundation for future collaborative research projects.

FIRAPY Medical sincerely appreciates the opportunity to support and participate in this respected scientific event, and remains committed to advancing non-invasive solutions in vascular and renal care—guided by academic evidence and clinical collaboration.

Want to know more?



Contact us for more detail


Learn more
Questions to FIRAPY
August 19, 2026
A new study published in Cells has provided further insight into the molecular responses of arterial endothelial cells following far-infrared (FIR) irradiation.  The study, conducted by researchers from Gunma Paz University, Japan, investigated the effects of FIR on human femoral artery endothelial cells (HFAECs) using an integrated multi-omics approach combining transcriptomics, proteomics, and phosphoproteomics. FIR irradiation was delivered using the WSTM TY101F far-infrared therapy unit manufactured by WS Far Infrared Medical Technology.
FIRAPY at MEDICA 2026 | Innovative Care for Dialysis Patients
August 19, 2026
Meet FIRAPY at MEDICA 2026 in Düsseldorf, November 16–19. Visit Hall 16, Booth B03-2 to explore innovative far infrared therapy for dialysis patient care.
More Posts